Physician profile
Gianina Usera
NPI 1295040590
$4,933.71
in general payments reported to CMS, 2019-2025
33 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.69 · 2020: $63.95 · 2021: $86.91 · 2022: $1,018 · 2023: $1,169 · 2024: $1,571 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,742.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $632.16 | 2023-2025 | Tepezza, Evenity, Prolia |
| Novo Nordisk INC | $607.75 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $435.52 | 2019-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $318.40 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Medtronic, INC. | $269.64 | 2022-2025 | Minimed 780g |
| Abbott Laboratories | $257.88 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $240.31 | 2022-2023 | Synthroid |
| Bayer Healthcare Pharmaceuticals INC. | $202.32 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $201.60 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Ibsa Pharma INC. | $200.67 | 2022-2025 | Tirosint, Licart, Tirosint |
| Beta Bionics, INC. | $178.14 | 2024 | Ilet Bionic Pancreas |
| Corcept Therapeutics | $152.33 | 2024-2025 | Korlym |
| Insulet Corporation | $147.73 | 2023-2024 | Omnipod |
| Antares Pharma, INC. | $144.33 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.74 | 2022-2025 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $122.94 | 2022-2023 | Unithroid |
| Sanofi-Aventis U.S. LLC | $96.08 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $87.86 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $68.95 | 2022-2023 | Afrezza |
| Ultragenyx Pharmaceutical INC. | $51.43 | 2022-2023 | |
| Halozyme INC | $47.53 | 2023 | |
| Ascensia Diabetes Care US INC. | $45.77 | 2023 | |
| Cequr Corporation | $42.66 | 2023-2024 | Cequr Simplicity |
| Horizon Therapeutics Plc | $40.82 | 2023 | Tepezza |
| Neurocrine Biosciences, INC. | $36.84 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.46 | 2024 | |
| Sanofi US Services INC. | $25.53 | 2024 | |
| Sequel Med Tech, LLC | $23.06 | 2025 | Twiist |
| Radius Health, INC. | $23.06 | 2024 | |
| Alexion Pharmaceuticals, INC. | $22.37 | 2025 | |
| Zealand Pharma US, INC. | $19.54 | 2022 | |
| Amryt Pharma Holdings LTD | $19.36 | 2023 | Mycapssa |
| Astellas Pharma US INC | $13.93 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gianina Usera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.